FK-962

N/A

Report date: 2023/02/11 20:37:40
NME

Base Information

Drug NameFK-962
Drug Alias NameFK-962
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin stimulants
TargetsSomatostatin
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A